Abstract
BACKGROUND: Subacute combined degeneration is an acquired myelopathy caused by vitamin B12 deficiency. Therapy with B12 leads to improvement in most but to complete recovery in only a few patients. Prognostic indicators in subacute combined degeneration are unknown; therefore, predicting complete recovery of neurologic deficits is challenging.
PURPOSE: To identify potential correlates of outcome and to generate hypotheses concerning predictors of complete resolution of neurologic deficits in subacute combined degeneration.
DATA SOURCE: We searched EMBASE (1974 to October 2005), MEDLINE (1968 to October 2005), and references from identified reports.
REPORTS SELECTION: Reports of patients with subacute combined degeneration containing results of magnetic resonance imaging (MRI) and description of outcome and 1 patient treated by the authors.
DATA EXTRACTION, SYNTHESIS: We extracted data from 45 reports and 57 patients (36 males, 21 females: age range: 10 to 81) with a diagnosis of subacute combined degeneration, and estimated the strength of association between clinical, laboratory, and radiological factors and complete resolution of signs and symptoms.
RESULTS: Eight patients (14%) achieved clinical resolution and 49 (86%) improved with B12 therapy. The absence of sensory dermatomal deficit, Romberg, and Babinski signs were associated with a higher complete resolution rate. Patients with MRI lesions in ≤7 segments and age less than 50 also appear to have higher rates of complete resolution.
CONCLUSIONS: B12 therapy is reported to stop progression and improve neurologic deficits in most patients with subacute combined degeneration. However, complete resolution only occurs in a small percentage of patients and appears to be associated with factors suggestive of less severe disease at the time of diagnosis.
Similar content being viewed by others
References
Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70:229–45.
Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76:871–81.
Shevell MI, Rosenblatt DS. The neurology of cobalamin. Can J Neurol Sci. 1992;19:472–86.
Licht DJ, Berry GT, Brooks DG, Younkin DP. Reversible subacute combined degeneration of the spinal cord in a 14-year-old due to a strict vegan diet. Clin Pediatr (Philadelphia). 2001;40:413–5.
Scalabrino G. Subacute combined degeneration one century later. The neurotrophic action of cobalamin (vitamin B12) revisited. J Neuropathol Exp Neurol. 2001;60:109–20.
Stabler SP, Allen RH. Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr. 2004;24:299–326.
Scalabrino G. Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp Neurol. 2005;192:463–79.
Kinsella LJ, Green R. ‘Anesthesia paresthetica’: nitrous oxide-induced cobalamin deficiency. Neurology. 1995;45:1608–10.
Pant SS, Asbury AK, Richardson EP Jr. The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol Scand. 1968;44(suppl 5):1–36.
Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency 1: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:90–8.
Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990;34:99–107.
Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet. 1995;346:85–9.
Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318:1720–8.
Bax L. MIX: Meta-analysis with Interactive eXplanations. 1.1 ed; 2005. Available at: http://www.mix-for-meta-analysis.info/index.html.
Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol. 1995;8:657–78.
Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med. 1999;159:1289–98.
Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992;40:1197–204.
Weimann J. Toxicity of nitrous oxide. Best Pract Res Clin Anaesthesiol. 2003;17:47–61.
Marie RM, Le Biez E, Busson P, et al. Nitrous oxide anesthesia-associated myelopathy. Arch Neurol. 2000;57:380–2.
Sesso RM, Iunes Y, Melo AC. Myeloneuropathy following nitrous oxide anesthaesia in a patient with macrocytic anaemia. Neuroradiology. 1999;41:588–90.
Pema PJ, Horak HA, Wyatt RH. Myelopathy caused by nitrous oxide toxicity. Am J Neuroradiol. 1998;19:894–6.
Berger JR, Quencer R. Reversible myelopathy with pernicious anemia: clinical/MR correlation. Neurology. 1991;41:947–8.
Tracey JP, Schiffman FJ. Magnetic resonance imaging in cobalamin deficiency. Lancet. 1992;339:1172–3.
Timms SR, Cure JK, Kurent JE. Subacute combined degeneration of the spinal cord: MR findings. Am J Neuroradiol. 1993;14:1224–7.
Murata S, Naritomi H, Sawada T. MRI in subacute combined degeneration. Neuroradiology. 1994;36:408–9.
Tajima Y, Mito Y, Owada Y, Moriwaka F, Tashiro K. MR appearance of subacute combined degeneration of the spinal cord. Jpn J Psychiatry Neurol. 1994;48:611–4.
Wolansky LJ, Goldstein G, Gozo A, Lee HJ, Sills I, Chatkupt S. Subacute combined degeneration of the spinal cord: MRI detection of preferential involvement of the posterior columns in a child. Pediatr Radiol. 1995;25:140–1.
Rosener M, Dichgans J. Severe combined degeneration of the spinal cord after nitrous oxide anaesthesia in a vegetarian. J Neurol Neurosurg Psychiatry. 1996;60:354.
Duprez TP, Gille M, Vande Berg BC, et al. MRI of the spine in cobalamin deficiency: the value of examining both spinal cord and bone marrow. Neuroradiology. 1996;38:511–5.
Larner AJ, Zeman AZ, Allen CM, Antoun NM. MRI appearances in subacute combined degeneration of the spinal cord due to vitamin B12 deficiency. J Neurol Neurosurg Psychiatry. 1997;62:99–100.
Ng VW, Gross M, Clifton A. Case report: MR appearances in vitamin B12 neuropathy. Clin Radiol. 1997;52:394–6.
Rodriguez-Pena F, Repetto JA, Contreras A, Gomez-Cardenas E, Garcia-Vazquez F. Nuclear magnetic resonance in subacute combined degeneration of the spinal cord. A case report. Rev Neurol. 1997;25:2077–8.
Felten D, Naccache L, Sarrazin J, Lapeyre E, Taillia H, Renard J. Pernicious anemia and subacute combined degeneration of the spinal cord: MR findings. Neurology. 1998;50(4 suppl 4):120.
Beltramello A, Puppini G, Cerini R, et al. Subacute combined degeneration of the spinal cord after nitrous oxide anaesthesia: role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 1998;64:563–4.
Yamada K, Shrier DA, Tanaka H, Numaguchi Y. A case of subacute combined degeneration: MRI findings. Neuroradiology. 1998;40:398–400.
Giron JM, Munoz A, Caro P, Rodriguez F, Vila MJ. Anestesia parestesica: aportacion de un nuevo caso y estudio evolutivo por resonancia magnetica. Neurologia. 1998;13:307–10.
Karacostas D, Artemis N, Bairactaris C, Tsitourides I, Milonas I. Cobalamin deficiency: MRI detection of posterior columns involvement and posttreatment resolution. J Neuroimaging. 1998;8:171–3.
Katsaros VK, Glocker FX, Hemmer B, Schumacher M. MRI of spinal cord and brain lesions in subacute combined degeneration. Neuroradiology. 1998;40:716–9.
Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lucking CH. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry. 1998;65:822–7.
Yousry TA, Strupp M, Bruning R. Common variable immunodeficiency leading to spinal subacute combined degeneration monitored by MRI. J Neurol Neurosurg Psychiatry. 1998;64:663–6.
Sharma S, Khilnani GC, Berry M. Case of the season. Megaloblastic anemia with subacute combined degeneration (SCD) of the spinal cord. Semin Roentgenol. 1999;34:2–4.
Bassi SS, Bulundwe KK, Greeff GP, Labuscagne JH, Gledhill RF. MRI of the spinal cord in myelopathy complicating vitamin B12 deficiency: two additional cases and a review of the literature. Neuroradiology. 1999;41:271–4.
Locatelli ER, Laureno R, Ballard P, Mark AS. MRI in vitamin B12 deficiency myelopathy. Can J Neurol Sci. 1999;26:60–3.
Kuker W, Hesselmann V, Thron A, de Simone A. MRI demonstration of reversible impairment of the blood-CNS barrier function in subacute combined degeneration of the spinal cord. J Neurol Neurosurg Psychiatry. 1997;62:298–9.
Warmuth-Metz M, Naumann M, Solymosi L. MRT bei funikularer Myelose. Rofo: Fortschr Geb Rontgenstr Nuklearmed. 1999;170:591–3.
Karantanas AH, Markonis A, Bisbiyiannis G. Subacute combined degeneration of the spinal cord with involvement of the anterior columns: a new MRI finding. Neuroradiology. 2000;42:115–7.
Yu MK, Rodgers GM. Detection of occult cobalamin deficiency by magnetic resonance imaging. Am J Hematol. 2000;65:83–4.
Ravina B, Loevner LA, Bank W. MR findings in subacute combined degeneration of the spinal cord: a case of reversible cervical myelopathy. Am J Roentgenol. 2000;174:863–5.
Coignard P, Lemesle M, Madinier G, et al. Interet de l’imagerie par resonance magnetique dans la sclerose combinee de la moelle par carence en vitamine B12. Rev Neurol (Paris). 2000;156:1000–4.
Jongen JC, Koehler PJ, Franke CL. Gecombineerde strengziekte door vitamine-B12-deficientie: eenvoudige diagnose, effectieve therapie. Ned Tijdschr Geneeskd. 2001;145:1229–33.
Cornejo W, Gonzalez F, Toro ME, Cabrera D. Degeneracion combinada subaguda. Descripcion de un caso en un nino vegetariano estricto. Rev Neurol. 2001;33:1154–7.
Ilniczky S, Jelencsik I, Kenez J, Szirmai I. MR findings in subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia—two cases. Eur J Neurol. 2002;9:101–4.
Beauchet O, Exbrayat V, Navez G, Blanchon MA, Quang BL, Gonthier R. Sclerose combinee medullaire revelatrice d’une carence en vitamine B12: particularites geriatriques a propos d’un cas evalue par imagerie par resonance magnetique nucleaire. Rev Med Intern. 2002;23:322–7.
Pittock SJ, Payne TA, Harper CM. Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. Mayo Clin Proc. 2002;77:291–4.
Srikanth SG, Jayakumar PN, Vasudev MK, Taly AB, Chandrashekar HS. MRI in subacute combined degeneration of spinal cord: a case report and review of literature. Neurol India. 2002;50:310–2.
Penas M, Blanco A, Villarejo A, Juntas R, Miranda P, Martinez A. Degeneracion combinada subaguda medular: hallazgos en la resonancia magnetica. Neurologia. 2002;17:447–8.
Krishna KK, Arafat AS, Ichaporia NR, Jain MM. MRI findings in cobalamin deficiency. J Clin Neurosci. 2003;10:84–5.
Fritschi J, Sturzenegger M. Spinal MRI supporting myelopathic origin of early symptoms in unsuspected cobalamin deficiency. Eur Neurol. 2003;49:146–50.
Berlit P, Ringelstein A, Liebig T. Spinal MRI precedes clinical improvement in subacute combined degeneration with B12 deficiency. Neurology. 2004;63:592.
Ahn SC, Brown AW. Cobalamin deficiency and subacute combined degeneration after nitrous oxide anesthesia: a case report. Arch Phys Med Rehabil. 2005;86:150–3.
Naidich MJ, Ho SU. Case 87: subacute combined degeneration. Radiology. 2005;237:101–5.
Plotas AA, Stamoulis E, Kehagias D, Papadopoulos A, Lahanis SV. Subacute combined degeneration of the spinal cord. Eur Radiol. 2005;15:1775–8.
Morishita A, Tomita H, Takaishi Y, Nishihara M, Kohmura E. A case of subacute combined degeneration of the spinal cord diagnosed by characteristic findings of magnetic resonance imaging: case report and review of 22 cases. No Shinkei Geka. 2005;33:489–95.
Author information
Authors and Affiliations
Additional information
The authors have no conflicts of interest to report. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.
This research was supported in part by the Intramural Research Program of the NIH, NIH Clinical Center, Department of Anesthesia and Surgical Services.
Rights and permissions
About this article
Cite this article
Vasconcelos, O.M., Poehm, E.H., McCarter, R.J. et al. Potential outcome factors in subacute combined degeneration. J GEN INTERN MED 21, 1063–1068 (2006). https://doi.org/10.1111/j.1525-1497.2006.00525.x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2006.00525.x